HAE financials
Haemonetics (HAE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
HAE income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2026 | $1.33B | $743.59M | $241.40M | $97.31M | 2.05 |
| 2025 | $1.36B | $778.55M | $221.82M | $167.68M | 3.31 |
| 2024 | $1.31B | $711.91M | $164.88M | $117.56M | 2.29 |
| 2023 | $1.17B | $622.87M | $156.03M | $115.40M | 2.24 |
| 2022 | $993.20M | $530.77M | $80.75M | $43.38M | 0.84 |
| 2021 | $870.46M | $428.45M | $89.75M | $79.47M | 1.55 |
- HAE revenue was $1.33B in fiscal 2026, net income $97.31M.
Updated 2026-11-02 17:15 UTC